The PE Ratio as of November 2024 (TTM) for Sio Gene Therapies Inc. (SIOX) is -1.06

According to Sio Gene Therapies Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.06. This represents a change of -26.73% compared to the average of -1.45 of the last 4 quarters.

Sio Gene Therapies Inc. (SIOX) Historical PE Ratio (quarterly & annually)

How has SIOX PE Ratio performed in the past?

The mean historical PE Ratio of Sio Gene Therapies Inc. over the last ten years is -2.99. The current -1.06 PE Ratio has changed 3.44% with respect to the historical average. Over the past ten years (40 quarters), SIOX's PE Ratio was at its highest in in the June 2022 quarter at -0.79. The PE Ratio was at its lowest in in the September 2015 quarter at -26.55.

Sio Gene Therapies Inc. (SIOX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Sio Gene Therapies Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sio Gene Therapies Inc. (SIOX) Average PE Ratio

How has SIOX PE Ratio performed in the past?

The current PE Ratio of Sio Gene Therapies Inc. (SIOX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Sio Gene Therapies Inc. (SIOX) PE Ratio vs. Peers

How is SIOX’s PE Ratio compared to its peers?

Sio Gene Therapies Inc.’s PE Ratio is less than Magenta Therapeutics, Inc. (-0.15), less than TRACON Pharmaceuticals, Inc. (0), less than ARCA biopharma, Inc. (0.02), greater than Neoleukin Therapeutics, Inc. (-58.03), greater than CytomX Therapeutics, Inc. (-5.86), less than Assembly Biosciences, Inc. (5.48), greater than Instil Bio, Inc. (-2.34), greater than Nuvation Bio Inc. (-2.26), greater than Rezolute, Inc. (-1.44), greater than XOMA Corporation (-4.94), greater than Vincerx Pharma, Inc. (-11.81), less than Protara Therapeutics, Inc. (-0.43), greater than Vaccinex, Inc. (-1.27), less than Monopar Therapeutics Inc. (-0.39), less than Miromatrix Medical Inc. (-0.54), greater than Surrozen, Inc. (-7.13), less than Tempest Therapeutics, Inc. (-0.66), less than SAB Biotherapeutics, Inc. (-0.66), less than Aligos Therapeutics, Inc. (-0.64), greater than Molecular Partners AG (-1.63), greater than null (-2.50),

Build a custom stock screener for Sio Gene Therapies Inc. (SIOX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sio Gene Therapies Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sio Gene Therapies Inc. (SIOX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sio Gene Therapies Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.